Smart investing isn't about chasing fads or timing every market dip perfectly — it is about backing quality ASX 200 shares and letting them compound your wealth over time.
Whether you're building a portfolio from scratch or adding to an existing one, a $5,000 investment can go a long way when deployed into the right shares.
Here are three ASX 200 shares that analysts think could be smart buy and hold options for investors today. They are as follows:
Breville Group Ltd (ASX: BRG)
Breville, best known for its coffee machines and kitchen appliances, is one of Australia's quiet global success stories. The appliance manufacturer has built a premium brand, expanded aggressively across the US and Europe, and continues to invest heavily in product design and innovation.
Its global footprint is still growing, and strong margins should help support long-term profitability. While its share price has been volatile in recent times, Breville's fundamentals remain intact. For investors looking to back a well-run consumer business with international upside, it could be worth a closer look.
Macquarie certainly believes this is the case. The broker currently has an outperform rating and $41.10 price target on its shares.
Goodman Group (ASX: GMG)
Another ASX 200 share to consider for a $5,000 investment is Goodman Group. If you believe in the future of e-commerce, cloud computing, and artificial intelligence, Goodman is one way to invest in the infrastructure powering it all.
The company develops and manages high-end industrial properties — including warehouses and data centres — in some of the world's most in-demand urban areas.
Goodman has been growing its earnings at a strong rate for many years thanks to its disciplined capital allocation and strong tenant demand. And with a growing development pipeline and exposure to next-generation digital infrastructure, it appears well placed to benefit from structural growth for years to come.
Analysts at Citi believe the company's outlook is very positive. So much so, they have put a buy rating and $40.00 price target on Goodman's shares.
ResMed Inc. (ASX: RMD)
ResMed is a global leader in sleep and respiratory care, best known for its CPAP machines and cloud-connected health platforms.
The company has faced some pressure in recent times due to concerns about weight-loss drugs affecting demand for sleep apnoea treatment. However, analysts now agree that these drugs are not category killers and could in fact boost demand for its offering. As a result, the long-term growth story remains intact.
Sleep disorders are significantly underdiagnosed, and ResMed's scale, distribution, and digital ecosystem give it a powerful competitive advantage.
Goldman Sachs is very positive on the company's future and has a conviction buy rating and $49.00 price target on its shares.
